Recent Advances in Chemical Tools for the Regulation and Study of Protein Lysine Methyltransferases
-
- Tomoya Hirano
- Institute of Biomaterials and Bioengineering Tokyo Medical and Dental University (TMDU), 2-3-10 Kanda-Surugadai, Chiyoda-ku Tokyo 101-0062 Japan
-
- Shuichi Mori
- Institute of Biomaterials and Bioengineering Tokyo Medical and Dental University (TMDU), 2-3-10 Kanda-Surugadai, Chiyoda-ku Tokyo 101-0062 Japan
-
- Hiroyuki Kagechika
- Institute of Biomaterials and Bioengineering Tokyo Medical and Dental University (TMDU), 2-3-10 Kanda-Surugadai, Chiyoda-ku Tokyo 101-0062 Japan
この論文をさがす
説明
<jats:title>Abstract</jats:title><jats:p>Protein lysine methyltransferases (PKMTs) are epigenetic regulators that modulate gene transcription and physiological functions by catalyzing the post‐translational methylation of specific lysine residues of substrate proteins, such as histones. They are considered to be candidate drugs for the treatment of various diseases, including acute myeloid leukemia, and in the past decade, potent and selective inhibitors of individual PKMTs have been developed. Some are currently under clinical trial. In this review, we will focus on some breakthrough PKMT inhibitors, and discuss chemistry‐based methods available for elucidation of the physiological functions of PKMTs and methylated proteins.</jats:p>
収録刊行物
-
- The Chemical Record
-
The Chemical Record 18 (12), 1745-1759, 2018-08-06
Wiley